Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer
Clinical trial NCT02396108 · UNKNOWN
Trial details
- NCT number
- NCT02396108
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-03-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.